Wordt geladen...
Priorities for developing respiratory syncytial virus vaccines in different target populations
The development of an effective vaccine against respiratory syncytial virus (RSV) has been hampered by major difficulties that occurred in the 1960s when a formalin-inactivated vaccine led to increased severity of RSV disease after acquisition of the virus in the RSV season after vaccination. Recent...
Bewaard in:
| Gepubliceerd in: | Sci Transl Med |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7613568/ https://ncbi.nlm.nih.gov/pubmed/32188721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aax2466 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|